Meridian Wealth Partners’s Halozyme HALO Stock Holding History

Meridian Wealth Partners’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-41	Closed	-$2K	–	583
2021 Q1	$2K	Buy	+41	New	+$1.87K	﹤0.01%	990

Other funds holding HALO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Meridian Wealth Partners's HALO Position: Q2 2021 in Review

Meridian Wealth Partners sold out of Halozyme (HALO) in Q2 2021, closing a stake of 41 shares — an estimated $2K sold.

Meridian Wealth Partners first reported a position in HALO in Q1 2021 and held it in 1 quarter. The position peaked at $2K in Q1 2021. 313 funds tracked by Wall St. Rank hold HALO as of Q2 2021.

Meridian Wealth Partners reported no remaining Halozyme position as of Q2 2021 after selling out during the quarter.
Meridian Wealth Partners sold 41 Halozyme shares in Q2 2021, an estimated $2K.
Meridian Wealth Partners first reported a position in Halozyme in Q1 2021 and held it in 1 quarter.
Meridian Wealth Partners's Halozyme position peaked at $2K in Q1 2021.
313 funds tracked by Wall St. Rank held Halozyme as of Q2 2021.

Based on Meridian Wealth Partners's 13F filing for Q2 2021, filed 12 Aug 2021.